Trial Information

Summary: Lupus Nephritis - Adults and Minors

People with Lupus Nephritis (LN) are asked to participate in a research study being conducted by the Feinstein Institute for Medical Research.

You may be eligible to participate in this study if you:

• Are 16 years of age or older
• Have a diagnosis of Systemic Lupus Erythematosis (SLE) along with nephritis related to lupus
• Have had a kidney biopsy performed within 12 months

You may not participate in this study if you:

• Have kidney disease unrelated to SLE (i.e. diabetes, renovascular disease whether or not related to antiphospholipid syndrome)
• Have received MMF, CTX or azathioprine within the past 6 months
• Have received methotrexate within 2 weeks prior to screening or pulse IV steroids within 30 days of screening
• Have received abatacept, rituximab, belimumab, or other B-cell modulating agent
• Had a kidney transplant
• Have an infection requiring hospitalization
• Are HIV positive or have Hepatitis B or C
• Have a history of tuberculosis infection without treatment in the past year
• Have been diagnosis or have a family history of Creutzfeldt-Jakob disease (CJD)
• Have a history of heart disease, cancer, or abnormal blood count
• Have a planned major surgery during the trial period
• Are pregnant, breastfeeding, or intend to become pregnant during the study
• Have taken another experimental drug within the last 12 months
• Have participated in another research study within the last 30 days
• Have received any type of vaccination within 30 days of study participation.
• Have a condition such as asthma or inflammatory bowel disease that requires the use of corticosteroids

If you would like to learn more about participating in this study, please send an e-mail message using the form below.